Freedom of information (FOI) releases from MHRA

This is a disclosure log of Medicines and Healthcare products Regulatory Agency's responses to freedom of information (FOI) or environmental information regulations (EIR) requests that might be of wider public interest.

If you can't find the information you're looking for, you can make a new FOI request.

Filters

Clear filters

  • Keywords filters

  • Year filters

  • Month filters

674 disclosures

  1. Freedom of Information

    I am writing to request information under the Freedom of Information Act 2000 regarding your council’s planned Information and Communications Technology (ICT) expenditure for the upcoming fiscal year. Specifically, I would like to know: 1. The allocated budget for ICT in the next fiscal year. 2. A breakdown of planned spending within the ICT budget, including major projects or initiatives identified by name. 3. Any documentation or reports that outline your ICT priorities or strategies for the next fiscal year. If this information is available in a summarised or report format, please provide the document(s) directly. Should any part of this request exceed the cost or time limits stipulated under the Act, I would appreciate it if you could advise on how I might refine my request to ensure compliance.

    Published: 31 January 2025

  2. Promogran Prisma

    i want to check whether promogran prisma got any adverse effects?anyone got brain bleed and die using it?

    Published: 31 January 2025

  3. FOI, MHRA and Releaf, Yellow Card, Cannabis

    I would like to make a request for the following information. - This notice was published this week https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fadvertising-investigations-november-2024%2Ffcfb0961-d088-4697-b29d-229c460e864b&data=05%7C02%7Cfoi.request%40mhra.gov.uk%7C21e18c34cebc465b44c408dd211d6168%7Ce527ea5c62584cd2a27f8bd237ec4c26%7C0%7C0%7C638703133246385389%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C80000%7C%7C%7C&sdata=sgQzNzsCsE27zmze39jpbQvxOVHAK8odErrxbfLnr1s%3D&reserved=0. I would like a breakdown of all complaints received against Releaf, including how many in total and what the complaint was. - I would like any communication between the MHRA and Releaf. -I would like a breakdown of yellow card reports for all medicinal cannabis products for 2024,2023,2022, 2021, 2020. I would like the total number of complaints and a breakdown of what condition was reported in each instance.

    Published: 31 January 2025

  4. MHRA Yellow Card Contact Us Form Submission

    I've come across two reported incidents within the healthcare organisation i work for regarding Bunov, buprenorphine 5 microgram patches and coming of the patients, possibly due to the adhesive. has there been many reports submitted for this issue, batch 426868 and Exp date : 08/2025

    Published: 31 January 2025

  5. FOI request

    I am doing a research project investigating call-off contracts in the public sector. I have identified two potential call-off contracts awarded by Medicines & Healthcare Products Regulatory Agency, but I can't find details of the framework agreements they were awarded from. I have attached an Excel file that contains the information I am looking at. The last two columns ("Title of framework used" and "Further framework info") is where I am missing information. Please could you provide the name of the specific framework agreements or DPS agreements used here. If there is any further info which you think would help me locate the framework agreements (e.g., a link to the framework's Contract Finder or FTS listing, the framework provider, or a widely-used reference number such as CCS's RM codes), please use the final column for this. Please note that I have identified these contracts as possible call-off contracts, so some of them might not be. Some could be, for instance, procured directly (without being called off from a framework agreement), or could be themselves notices of the establishment of a framework agreement. Therefore I would kindly ask you to specify in these incidences what kind of procurement was used in the "Title of framework used" column. I have provided the title, description, the publication date, and procedure type used to award each potential call-off, as well as a URL link to the call-off in question and a unique reference ID for each potential call-off. Please let me know if there is anything else you need to complete the request.

    Published: 31 January 2025

  6. Freedom of Information Request: Hemgenix PLGB 15036/0160

    We would kindly like to request the following document under the Freedom of Information (FOI) Act concerning Hemgenix 1x1013 genome copies/mL concentrate for solution for infusion, PLGB 15036/0160: Current available electronic copy - PSUR, periodic safety update report (PBRER)

    Published: 27 January 2025

  7. Safety concerns regarding Citalopram

    Under the Freedom of Information Act, I would like to request the following information from the MHRA: 1. How many safety concerns were submitted per year to the MHRA via the Yellow Card Scheme from 2019 to 2024 concerning the drug, Citalopram (also known as Escitalopram)? 2. What safety concern is the most predominant that is reported about the drug, Citalopram (also known as Escitalopram)? 3. Is it safe to prescribe antidepressants (such as Citalopram) to patients under the age of 25, when there is a risk of suicide ideation?

    Published: 26 January 2025

  8. Modular Seating Systems for Disabled Children

    Any documents (including email or other communications) in relation to safety incidents involving modular seating systems for disabled children including those manufactured by: (i) Schuchmann; (ii) Tendercare; (iii) Jenx; (iv) Rifton; (v) Leckey; (vi) Everday; (vii) Mygo; (viii) Squiggles; (ix) R82 by Etac; and (x) Liwcare. This should include (but not be limited to) communications between the MHRA and: (a) the manufacturers listed at (i) to (x); (b) UK local authorities; and/or (c) the NHS. To the extent such documents contain personal data or sensitive personal data of third parties please can these be provided with appropriate redactions to protect such information (and not withheld).

    Published: 26 January 2025

  9. FOIA Request the placebo-controlled trials

    Please could you provide me with copies of all of the placebo-controlled trials considered as part of the authorisation process for each of the current vaccines in the recommended childhood vaccine schedule? I'd like to receive these via pdf or word document via email to this address.

    Published: 26 January 2025

  10. Product License numbers (PL/PLGB number)

    Would it be possible to obtain a list of all active Product License numbers (PL/PLGB/PLNI number) for all products with a Marketing authorisation in the UK? Including the product they relate to and the authorisation holder. We are interested to receive information from 27th of November 2023 until today's date. For your convenience, attaching information received from similar FOI request, dated 27.11.2023

    Published: 26 January 2025